Covered recipient · General Payments record
MATTHEW SIMMONS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$1,975.43
- Reported across 121 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $519.21 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $357.32 | 25 |
| Ardelyx, Inc. | $38.02 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.81 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19.90 | 1 |
| Gilead Sciences, Inc. | $17.87 | 1 |
| Janssen Biotech, Inc. | $17.61 | 1 |
| Lilly USA, LLC | $15.54 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $15.52 | 1 |
| Fresenius Kabi USA, LLC | $13.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.38 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200551 | CMS |
| ABBVIE INC. | $19.65 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200553 | CMS |
| ABBVIE INC. | $20.79 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200555 | CMS |
| ABBVIE INC. | $23.45 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200557 | CMS |
| ABBVIE INC. | $7.91 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200559 | CMS |
| ABBVIE INC. | $7.60 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200561 | CMS |
| ABBVIE INC. | $4.55 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200563 | CMS |
| ABBVIE INC. | $14.69 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200565 | CMS |
| ABBVIE INC. | $7.58 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200567 | CMS |
| ABBVIE INC. | $11.80 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200569 | CMS |
| ABBVIE INC. | $9.38 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200571 | CMS |
| ABBVIE INC. | $19.95 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200573 | CMS |
| ABBVIE INC. | $19.78 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200575 | CMS |
| ABBVIE INC. | $22.51 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200577 | CMS |
| ABBVIE INC. | $15.02 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200579 | CMS |
| ABBVIE INC. | $9.71 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200581 | CMS |
| ABBVIE INC. | $13.63 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200583 | CMS |
| ABBVIE INC. | $17.26 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200585 | CMS |
| ABBVIE INC. | $6.17 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200587 | CMS |
| ABBVIE INC. | $12.12 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200589 | CMS |
| ABBVIE INC. | $8.04 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200591 | CMS |
| ABBVIE INC. | $15.69 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200593 | CMS |
| ABBVIE INC. | $18.04 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200595 | CMS |
| ABBVIE INC. | $13.03 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200597 | CMS |
| ABBVIE INC. | $18.59 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108200599 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $15.52 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146975688 | CMS |
| Ardelyx, Inc. | $19.11 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146745765 | CMS |
| Ardelyx, Inc. | $18.91 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146745767 | CMS |
| Fresenius Kabi USA, LLC | $13.62 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146957741 | CMS |
| Gilead Sciences, Inc. | $17.87 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133728313 | CMS |
| Janssen Biotech, Inc. | $17.61 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078473516 | CMS |
| Lilly USA, LLC | $15.54 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135744416 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19.90 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153602451 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.81 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137824242 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.